Medicine & Life Sciences
Interstitial Lung Diseases
100%
Myositis
64%
Dermatomyositis
42%
Autoantibodies
34%
Idiopathic Pulmonary Fibrosis
30%
Lung
25%
Antisynthetase syndrome
20%
Rheumatoid Arthritis
17%
Pulmonary Fibrosis
14%
Inositol 1,4,5-Trisphosphate Receptors
14%
Connective Tissue Diseases
11%
Pneumonia
10%
pirfenidone
10%
Brain
9%
Inositol 1,4,5-Trisphosphate
8%
Antibodies
8%
Mortality
7%
Muscles
7%
Phenotype
7%
TFII Transcription Factors
7%
IFIH1 Interferon-Induced Helicase
6%
Quality of Life
6%
Therapeutics
6%
Idiopathic Interstitial Pneumonias
6%
Inositol
6%
Vital Capacity
6%
Muscular Diseases
6%
inositol-1,3,4,5-tetrakisphosphate
6%
Palliative Care
6%
Cough
6%
Lung Diseases
5%
Inclusion Body Myositis
5%
Immunotherapy
5%
Signal Recognition Particle
5%
Extrinsic Allergic Alveolitis
5%
Biopsy
5%
Population
5%
Placebos
5%
nintedanib
5%
Anti-Idiotypic Antibodies
5%
Clinical Trials
5%